UNITED THERAPEUTICS Corp 4

Non-employee director Nilda Mesa received routine annual equity awards of 380 RSUs and options for 1,190 United Therapeutics (UTHR) shares on July 22, 2026.

On July 22, 2026, non-employee director Nilda Mesa of United Therapeutics Corporation received an annual equity compensation package consisting of 380 restricted stock units and stock options for 1,190 shares of common stock, both reported at a grant/transaction price of $0.00 as routine director awards. The RSUs, each representing one share of common stock upon vesting, and the options are scheduled to vest fully on the earlier of June 25, 2027 (the anticipated next annual meeting date) or the next annual meeting of shareholders, in line with the company’s standard non-employee director compensation policy. Following these awards, Mesa’s direct beneficial ownership in United Therapeutics common stock increased to a total of 5,678 shares, and the Form 4 notes that the RSUs do not have an expiration date while the stock options carry an expiration date of July 22, 2033.

Filing Facts

CIK

1082554

Ticker

UTHR

Form

4

Source Type

fda

Accession

0001756697-26-000003

Alert Tier

5